Page last updated: 2024-08-16

pindolol and paroxetine

pindolol has been researched along with paroxetine in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	22 (42.31)	18.2507
2000's	22 (42.31)	29.6817
2010's	8 (15.38)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ahman, M; Holmén, AG; Wan, H	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Bellman, K; Knegtel, RM; Settimo, L	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Baba, S; Horisawa, T; Kato, T; Kinomura, N; Kodo, T; Koyama, K; Masumoto, S; Matsumoto, K; Matsumoto, Y; Oki, H; Yabuuchi, K; Yoshinaga, H	1
Bowery, NG; Johnson, AM; Nelson, DR; Palmer, KJ; Pratt, GD	1
Bird, ED; Crino, PB; Plager, MD; Vogt, BA	1
Crino, PB; Vogt, BA; Volicer, L; Wiley, RG	1
Auerbach, SB; Hjorth, S	1
Alvarez, E; Artigas, F; Perez, V	1
Frankfurt, M; McEwen, BS; McKittrick, CR; Mendelson, SD	1
Clark, M; Post, RM; Weiss, SR	1
Battaglia, G; Pinto, W	1
Kraus, RP	1
Harte, R; Holland, C; Isaac, MT; Tome, MB	1
Cloninger, CR; Isaac, MT; Tome, MB; Watson, JP	1
Isaac, MT; Tome, MB	4
Bordet, R; Dupuis, B; Thomas, P	2
Artigas, F; Franchini, L; Gasperini, M; Perez, J; Sforzini, L; Smeraldi, E; Zanardi, R	1
Cryan, JF; Leonard, BE; McGrath, C; Norman, TR	1
Baker, GB; Bourin, M; Colombel, MC; Redrobe, JP	1
Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J	1
Clifford, EM; Cowen, PJ; Gartside, SE; Sharp, T	1
Dannon, PN; Grunhaus, LJ; Hirschmann, S; Iancu, I; Sasson, Y; Zohar, J	1
Béïque, JC; Blier, P; de Montigny, C; Debonnel, G	1
Broft, A; Laruelle, M; Martinez, D	1
Bosker, FJ; Cremers, TI; den Boer, JA; Westerink, BH; Wiersma, LJ; Wikström, HV	1
Chao, J; Hami, S; Sareen, J; Stein, MB	1
Aldegunde, M; Míguez, I; Míguez, JM; Paz-Valiñas, L	1
Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R	1
Bailey, J; Bell, C; Nutt, D; Rich, A; Wilson, S	1
Anand, A; Berman, RM; Charney, DS; Lynch-Colonese, K; Perry, EB; Sanacora, G	1
Amsterdam, JD; Brunswick, DJ; Chopra, M; Goodman, DB; O'Reardon, JP	1
Benedetti, F; Colombo, C; Cusin, C; Mandelli, L; Pirovano, A; Serretti, A; Smeraldi, E; Zanardi, R	1
Dauphin, A; Gruwez, B; Tod, M	1
Bourin, M; Chenu, F; David, DJ; Gardier, AM; Guiard, BP; Guilloux, JP; Repérant, C; Toth, M	1
Aichhorn, W; Bitterlich, W; Bondy, B; Geretsegger, C; Stelzig, R; Stuppaeck, C	1
Safarinejad, MR	1
Audi, EA; Graeff, FG; Roncon, CM; Sela, VR; Zangrossi, H	1
Audi, EA; Biesdorf, C; Graeff, FG; Ramos, DH; Sela, VR; Zangrossi, H	1

Reviews

2 review(s) available for pindolol and paroxetine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies. Biological psychiatry, 2000, Oct-15, Volume: 48, Issue:8 Topics: Animals; Brain; Cerebrovascular Circulation; Clinical Trials as Topic; Depressive Disorder, Major; Drug Synergism; Fluoxetine; Humans; Paroxetine; Pindolol; Rats; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed	2000

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.

Biological psychiatry, 2000, Oct-15, Volume: 48, Issue:8

Topics: Animals; Brain; Cerebrovascular Circulation; Clinical Trials as Topic; Depressive Disorder, Major; Drug Synergism; Fluoxetine; Humans; Paroxetine; Pindolol; Rats; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed

2000

Trials

17 trial(s) available for pindolol and paroxetine

Article	Year
Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International clinical psychopharmacology, 1997, Volume: 12, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Pindolol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1997
Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. Journal of affective disorders, 1997, Volume: 44, Issue:2-3 Topics: Adrenergic beta-Agonists; Adult; Depressive Disorder; Double-Blind Method; Ego; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Personality; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Temperament; Time Factors	1997
Selective serotonin reuptake inhibitors plus pindolol. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
How long should pindolol be associated with paroxetine to improve the antidepressant response? Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Male; Metoprolol; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Time Factors	1997
One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks. International clinical psychopharmacology, 1998, Volume: 13, Issue:4 Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1998
Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo. International clinical psychopharmacology, 1998, Volume: 13, Issue:4 Topics: Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; United Kingdom	1998
Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique. The American journal of psychiatry, 1998, Volume: 155, Issue:10 Topics: Adrenergic beta-Antagonists; Adult; Depressive Disorder; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	1998
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Archives of general psychiatry, 1999, Volume: 56, Issue:4 Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	1999
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2000
Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. The American journal of psychiatry, 2001, Volume: 158, Issue:10 Topics: Cross-Over Studies; Double-Blind Method; Humans; Paroxetine; Phobic Disorders; Pindolol; Placebos; Treatment Outcome	2001
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:1 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics	2002
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology, 2003, Volume: 166, Issue:2 Topics: Adult; Affect; Anxiety; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Eye Movements; Humans; Male; Paroxetine; Pindolol; Pulse; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep; Sleep, REM	2003
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Connecticut; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Hospitals, Veterans; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Veterans	2004
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Paroxetine; Pindolol; Prolactin	2004
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2005, Aug-05, Volume: 137B, Issue:1 Topics: Adult; Aged; Antidepressive Agents; CLOCK Proteins; Double-Blind Method; Drug Therapy, Combination; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mood Disorders; Multivariate Analysis; Paroxetine; Pindolol; Polymorphism, Genetic; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Time Factors; Trans-Activators; Treatment Outcome	2005
Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:2 Topics: Adult; Depression; Double-Blind Method; Drug Evaluation; Drug Synergism; Female; Humans; Inpatients; Male; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Statistics, Nonparametric; Time Factors	2008
Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:1 Topics: Adult; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Ejaculation; Humans; Male; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sexual Dysfunction, Physiological; Single-Blind Method	2008

Other Studies

33 other study(ies) available for pindolol and paroxetine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs. Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6 Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physical binding pocket induction for affinity prediction. Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19 Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A	2009
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT Bioorganic & medicinal chemistry, 2017, 01-01, Volume: 25, Issue:1 Topics: Animals; Antidepressive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dioxanes; Drug Partial Agonism; Humans; Male; Piperidines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins	2017
Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on beta-adrenoceptors in rat brain: autoradiographic and functional studies. Neuropharmacology, 1991, Volume: 30, Issue:6 Topics: Adrenergic beta-Antagonists; Amitriptyline; Animals; Autoradiography; Brain Chemistry; Cyclic AMP; Desipramine; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Male; Membranes; Paroxetine; Pindolol; Piperidines; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin Antagonists	1991
Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex. Neuroscience, 1990, Volume: 36, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Autoradiography; Cerebral Cortex; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Humans; Iodocyanopindolol; Ketanserin; Male; Middle Aged; Oxotremorine; Paroxetine; Pindolol; Piperidines; Pirenzepine; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, GABA-A; Receptors, Muscarinic; Receptors, Opioid; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes	1990
Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 252, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cerebral Cortex; Immunotoxins; Iodocyanopindolol; Male; Paroxetine; Pindolol; Piperidines; Rats; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes	1990
Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. European journal of pharmacology, 1994, Aug-01, Volume: 260, Issue:2-3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Autoreceptors; Citalopram; Hippocampus; Male; Microdialysis; Paroxetine; Pindolol; Piperazines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stereoisomerism	1994
Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of general psychiatry, 1994, Volume: 51, Issue:3 Topics: Adult; Aged; Animals; Depressive Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Paroxetine; Pilot Projects; Pindolol; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors	1994
Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology, 1994, Volume: 59, Issue:3 Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoradiography; Brain Chemistry; Carrier Proteins; Estrogens; Female; Gonadal Steroid Hormones; Hippocampus; Iodocyanopindolol; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Orchiectomy; Ovariectomy; Paroxetine; Pindolol; Progesterone; Rats; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins; Ventromedial Hypothalamic Nucleus	1994
Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. Neuroscience letters, 1993, Oct-14, Volume: 161, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amygdala; Animals; Autoradiography; Cerebral Cortex; Hippocampus; Iodine Radioisotopes; Iodocyanopindolol; Kindling, Neurologic; Male; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Receptors, Serotonin; Seizures; Tritium	1993
In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Neuroreport, 1993, Oct-25, Volume: 5, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Brain; Carrier Proteins; Cerebral Cortex; Dose-Response Relationship, Drug; Iodocyanopindolol; Ketanserin; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Pindolol; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins	1993
Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine. Depression, 1996, Volume: 4, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Arousal; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Paroxetine; Pindolol; Recurrence; Sympatholytics	1996
Selective serotonin reuptake inhibitors plus pindolol. The REEP. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Depressive Disorder; Fluoxetine; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
Pindolol-paroxetine combination. The American journal of psychiatry, 1997, Volume: 154, Issue:12 Topics: Adult; Age Factors; Animals; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pindolol; Placebos; Randomized Controlled Trials as Topic; Rats; Severity of Illness Index; Treatment Outcome	1997
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? European journal of pharmacology, 1998, Jul-03, Volume: 352, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hypothermia; Male; Olfactory Bulb; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists	1998
Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms. Journal of psychopharmacology (Oxford, England), 1998, Volume: 12, Issue:4 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amines; Animals; Antidepressive Agents; Apomorphine; Brain; Clonidine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Hypothermia; Indoles; Male; Mice; Motor Activity; Norepinephrine; Paroxetine; Pindolol; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming	1998
Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. British journal of pharmacology, 1999, Volume: 127, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Drug Synergism; Electrophysiology; In Vitro Techniques; Male; Membrane Potentials; Microdialysis; Paroxetine; Patch-Clamp Techniques; Penbutolol; Pindolol; Propanolamines; Prosencephalon; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes	1999
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:3 Topics: 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Cyclohexanols; Drug Synergism; Electrophysiology; Extracellular Space; Hippocampus; Injections, Intravenous; Male; Paroxetine; Pindolol; Piperazines; Pyramidal Cells; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Venlafaxine Hydrochloride	2000
Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? Biological psychiatry, 2001, Jul-01, Volume: 50, Issue:1 Topics: Animals; Antidepressive Agents; Autoreceptors; Brain; Cyclic AMP; Guinea Pigs; Hippocampus; Magnetic Resonance Imaging; Male; Paroxetine; Pindolol; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Synaptic Transmission; Time Factors; Tomography, Emission-Computed	2001
Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study. Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 365, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; Autoreceptors; Dendrites; Dose-Response Relationship, Drug; Hippocampus; Hydroxyindoleacetic Acid; Male; Microdialysis; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Stereoisomerism; Synaptic Transmission	2002
A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol. Journal of pharmacokinetics and pharmacodynamics, 2005, Volume: 32, Issue:5-6 Topics: Algorithms; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Models, Theoretical; Nonlinear Dynamics; Paroxetine; Pindolol; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Treatment Outcome	2005
Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:10 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Area Under Curve; Behavior, Animal; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Immobility Response, Tonic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Paroxetine; Pindolol; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming	2006
Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze. Life sciences, 2010, Sep-25, Volume: 87, Issue:13-14 Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Drug Combinations; Drug Interactions; Male; Panic Disorder; Paroxetine; Pindolol; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors	2010
Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze. Neuroscience letters, 2011, May-09, Volume: 495, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Drug Synergism; Escape Reaction; Male; Maze Learning; Panic; Paroxetine; Periaqueductal Gray; Pindolol; Piperazines; Pyridines; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists	2011